Faculty Profile

Mehrdad Alemozaffar, MD

Mehrdad Alemozaffar, MD

Assistant Professor of Urology, Department of Urology, Emory University School of Medicine

Email: malemoz@emory.edu


American Board of Urology


Dr. Alemozaffar's primary clinical interest is urologic oncology (cancers involving the bladder, kidney, adrenal gland, prostate, testes, and penis). He treats routine and complex malignancies with either open, robotic, or focal therapy techniques using advanced technology. He is highly skilled at performing such procedures as robotic cystectomy with intracorporeal urinary diversion for bladder cancer, robotic prostatectomy with extended lymph node dissection for high-risk prostate cancer, minimal ischemia robotic partial nephrectomy for kidney cancer, and the extraperitoneal approach to retroperitoneal lymph dissection for metastatic testis cancer.

Dr. Alemozaffar attended medical school at the University of California Los Angeles as the Deans Scholar and earned his MD in 2007 along with election to the Alpha Omega Alpha Honor society. He did his urology residency at the Harvard Program in Urology in Boston, MA, from 2008-2012, after which he completed his urologic oncology fellowship, combined with earning a Masters degree in Biomedical and Clinical Investigation, at the University of Southern California in 2014.

In his research, Dr. Alemozaffar pursues new therapies to improve outcomes and positively impact the lives of patients suffering from cancer. His passion for discovery began when he was an undergrad in the Howard Hughes Science Enrichment Program at the University of California San Diego. Influenced by this experience, he later enrolled in the one-year clinical research training program offered by the urologic oncology branch of the National Cancer Institute in Bethesda, MD.

Dr. Alemozaffar's current research interests include improving the diagnosis and prognostication of urologic tumors with molecular-based imaging and biopsies, understanding multifocality in prostate cancer and identification of the "index" lesion to treat with focal therapy, quality of life and outcomes following treatment for genitourinary malignancies, and clinical trials to evaluate new techniques and treatment options in urologic oncology.


View Dr. Alemozaffar's publications in PubMed.


  • Emory University Hospital

  • The Emory Clinic


  • MD, University of California Los Angeles, Class of 2007

  • Surgery Internship, Brigham and Women's Hospital, Boston, 2007-2008

  • Urology Residency, Harvard Program in Urology, Boston, 2008-2012

  • Fellowship in Urologic Oncology, University of Southern California, 2012-2014

  • MS, Biomedical Investigation, University of Southern California, 2014

Honors and Awards

  • Best of Posters, American Urologic Association, 2012

  • Best Video Abstract, World Congress of Endurology, 2010

  • Recognition for Teaching Excellence, Tufts School of Medicine, 2008

Clinical Interests

  • Adrenal cancer

  • Bladder cancer

  • Kidney cancer

  • Prostate cancer

  • Testicular cancer

Research Interests

  • Evaluation of new techniques and treatment options in urologic oncology

  • Improved diagnosis and prognostication of urologic tumors with molecular-based imaging and biopsies

  • Health related quality of life and outcomes following genitourinary malignancies

««return to top